相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。International Tailored Chemotherapy Adjuvant (ITACA) trial, a phase III multicenter randomized trial comparing adjuvant pharmacogenomic-driven chemotherapy versus standard adjuvant chemotherapy in completely resected stage II-IIIA non-small-cell lung cancer
S. Novello et al.
ANNALS OF ONCOLOGY (2022)
Challenges in the Use of Targeted Therapies in Non-Small Cell Lung Cancer
Joel Rivera-Concepcion et al.
CANCER RESEARCH AND TREATMENT (2022)
Twenty-Year Survival of Patients Operated on for Non-Small-Cell Lung Cancer: The Impact of Tumor Stage and Patient-Related Parameters
Olivier Schussler et al.
CANCERS (2022)
Perioperative targeted therapy for oncogene-driven NSCLC
Si -Yang Liu et al.
LUNG CANCER (2022)
Current Surgical Indications for Non-Small-Cell Lung Cancer
Nathaniel Deboever et al.
CANCERS (2022)
NSCLC as the Paradigm of Precision Medicine at Its Finest: The Rise of New Druggable Molecular Targets for Advanced Disease
Anna Michelotti et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Perioperative Systemic Therapy for Resectable Non-Small Cell Lung Cancer
Bharathi Muthusamy et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2022)
Development and validation of a host-dependent, PDL1-independent, biomarker to predict 6-month progression-free survival in metastatic non-small cell lung cancer (mNSCLC) patients treated with anti-PD1 immune checkpoint inhibitors (ICI) in the CERTIM Cohort: The ELY study
Pascaline Boudou-Rouquette et al.
EBIOMEDICINE (2021)
Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB-IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase 3 trial
Enriqueta Felip et al.
LANCET (2021)
The Reality of Lung Cancer Paradox: The Impact of Body Mass Index on Long-Term Survival of Resected Lung Cancer. A French Nationwide Analysis from the Epithor Database
Marco Alifano et al.
CANCERS (2021)
Prognostic utility of inflammation-based biomarkers, neutrophil-lymphocyte ratio and change in neutrophil-lymphocyte ratio, in surgically resected lung cancers
Daniel Thompson et al.
ANNALS OF THORACIC MEDICINE (2021)
Hypermetabolism is an independent prognostic factor of survival in metastatic non-small cell lung cancer patients
Anne Jouinot et al.
CLINICAL NUTRITION (2020)
Pre-Disease and Pre-Surgery BMI, Weight Loss and Sarcopenia Impact Survival of Resected Lung Cancer Independently of Tumor Stage
Philippe Icard et al.
CANCERS (2020)
Osimertinib in Resected EGFR-Mutated Non-Small-Cell Lung Cancer
Yi-Long Wu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Tumor Spread Through Air Spaces in Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis
Donglai Chen et al.
ANNALS OF THORACIC SURGERY (2019)
Muscle derangement and alteration of the nutritional machinery in NSCLC
Ilaria Trestini et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2019)
Prognostic Model for Resected Squamous Cell Lung Cancer: External Multicenter Validation and Propensity Score Analysis exploring the Impact of Adjuvant and Neoadjuvant Treatment
Sara Pilotto et al.
JOURNAL OF THORACIC ONCOLOGY (2018)
The eighth TNM classification system for lung cancer: A consideration based on the degree of pleural invasion and involved neighboring structures
Noriaki Sakakura et al.
LUNG CANCER (2018)
Immune Prophets of Lung Cancer: The Prognostic and Predictive Landscape of Cellular and Molecular Immune Markers
Ivana Catacchio et al.
TRANSLATIONAL ONCOLOGY (2018)
Obesity Suppresses Cell-Competition-Mediated Apical Elimination of RasV12-Transformed Cells from Epithelial Tissues
Ayana Sasaki et al.
CELL REPORTS (2018)
Sarcopenia in resected non-small cell lung cancer: let's move to patient-directed strategies
Philippe Icard et al.
JOURNAL OF THORACIC DISEASE (2018)
Development and validation of two prognostic nomograms for predicting survival in patients with non-small cell and small cell lung cancer
Hai-Fan Xiao et al.
ONCOTARGET (2017)
Body Mass Index and Total Psoas Area Affect Outcomes in Patients Undergoing Pneumonectomy for Cancer
Remi Hervochon et al.
ANNALS OF THORACIC SURGERY (2017)
Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
P. E. Postmus et al.
ANNALS OF ONCOLOGY (2017)
The Eighth Edition Lung Cancer Stage Classification
Frank C. Detterbeck et al.
CHEST (2017)
The estimation and use of predictions for the assessment of model performance using large samples with multiply imputed data
Angela M. Wood et al.
BIOMETRICAL JOURNAL (2015)
Development and Validation of a Nomogram for Predicting Survival in Patients With Resected Non-Small-Cell Lung Cancer
Wenhua Liang et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Risk Stratification Model for Resected Squamous-Cell Lung Cancer Patients According to Clinical and Pathological Factors
Sara Pilotto et al.
JOURNAL OF THORACIC ONCOLOGY (2015)
Immune therapy of non-small cell lung cancer. The future
Antonio Bobbio et al.
PHARMACOLOGICAL RESEARCH (2015)
Presence of B Cells in Tertiary Lymphoid Structures Is Associated with a Protective Immunity in Patients with Lung Cancer
Claire Germain et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2014)
Dendritic Cells in Tumor-Associated Tertiary Lymphoid Structures Signal a Th1 Cytotoxic Immune Contexture and License the Positive Prognostic Value of Infiltrating CD8+ T Cells
Jeremy Goc et al.
CANCER RESEARCH (2014)
The New Histologic Classification of Lung Primary Adenocarcinoma Subtypes Is a Reliable Prognostic Marker and Identifies Tumors With Different Mutation Status
Audrey Mansuet-Lupo et al.
CHEST (2014)
National perioperative outcomes of pulmonary lobectomy for cancer: the influence of nutritional status
Pascal Alexandre Thomas et al.
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2014)
Prognostic impact of alternative splicing-derived hMENA isoforms in resected, node-negative, non-small-cell lung cancer
Emilio Bria et al.
ONCOTARGET (2014)
Prognostic Significance of Vascular and Lymphatic Emboli in Resected Pulmonary Adenocarcinoma
Salvatore Strano et al.
ANNALS OF THORACIC SURGERY (2013)
Executive Summary Diagnosis and Management of Lung Cancer, 3rd ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
Frank C. Detterbeck et al.
CHEST (2013)
A unified inference procedure for a class of measures to assess improvement in risk prediction systems with survival data
Hajime Uno et al.
STATISTICS IN MEDICINE (2013)
Surrogate markers predicting overall survival for lung cancer: ELCWP recommendations
T. Berghmans et al.
EUROPEAN RESPIRATORY JOURNAL (2012)
Safety, Activity, and Immune Correlates of Anti-PD-1 Antibody in Cancer
Suzanne L. Topalian et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Adjuvant chemotherapy for resected non-small-cell lung cancer: future perspectives for clinical research
Maria Bonomi et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2011)
Preresection serum C-reactive protein measurement and survival among patients with resectable non-small cell lung cancer
Marco Alifano et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2011)
Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers
Michael J. Pencina et al.
STATISTICS IN MEDICINE (2011)
Multiple imputation using chained equations: Issues and guidance for practice
Ian R. White et al.
STATISTICS IN MEDICINE (2011)
Development and validation of a prediction model with missing predictor data: a practical approach
Yvonne Vergouwe et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2010)
Randomized Phase III Trial of Vinorelbine Plus Cisplatin Compared With Observation in Completely Resected Stage IB and II Non-Small-Cell Lung Cancer: Updated Survival Analysis of JBR-10
Charles A. Butts et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Adjuvant Cisplatin and Vinorelbine for Completely Resected Non-small Cell Lung Cancer Subgroup Analysis of the Lung Adjuvant Cisplatin Evaluation
Jean-Yves Douillard et al.
JOURNAL OF THORACIC ONCOLOGY (2010)
Imputing missing covariate values for the Cox model
Ian R. White et al.
STATISTICS IN MEDICINE (2009)
Lung Adjuvant Cisplatin Evaluation: A pooled analysis by the LACE collaborative group
Jean-Pierre Pignon et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Adjuvant Paclitaxel Plus Carboplatin Compared With Observation in Stage IB Non-Small-Cell Lung Cancer: CALGB 9633 With the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups
Gary M. Strauss et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
How should variable selection be performed with multiply imputed data?
Angela M. Wood et al.
STATISTICS IN MEDICINE (2008)
The Thoracic Surgery Scoring System (Thoracoscore): Risk model for in-hospital death in 15,183 patients requiring thoracic surgery
Pierre Emmanuel Falcoz et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2007)
分享论文
